Viewing Study NCT04361032


Ignite Creation Date: 2025-12-24 @ 9:49 PM
Ignite Modification Date: 2025-12-25 @ 7:27 PM
Study NCT ID: NCT04361032
Status: UNKNOWN
Last Update Posted: 2020-08-27
First Post: 2020-04-22
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Assessment of Efficacy and Safety of Tocilizumab Compared to DefeROxamine, Associated With Standards Treatments in COVID-19 (+) Patients Hospitalized In Intensive Care in Tunisia
Sponsor: Abderrahmane Mami Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module